BriaCell Therapeutics Corp. (OTCMKTS:BCTXF – Get Free Report) was up 4% on Thursday . The company traded as high as $3.69 and last traded at $3.61. Approximately 25,206 shares traded hands during mid-day trading, an increase of 1,256% from the average daily volume of 1,859 shares. The stock had previously closed at $3.47.
BriaCell Therapeutics Stock Up 12.6 %
The company’s 50-day moving average is $3.91 and its two-hundred day moving average is $1.83. The company has a market cap of $3.04 million, a P/E ratio of -0.01 and a beta of 1.09.
BriaCell Therapeutics Company Profile
BriaCell Therapeutics Corp. operates as a clinical-stage biotechnology company that specializes in immunotherapy for advanced breast cancer. It is advancing its targeted immunotherapy program by conducting a Phase I/IIA clinical trial with Bria-IMT in combination with an immune checkpoint inhibitor and a companion diagnostic test, BriaDx, to identify patients to benefit from Bria-IMT.
Featured Stories
- Five stocks we like better than BriaCell Therapeutics
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Conagra Stock Could Thrive as Tariffs Hit Other Sectors
- What Are Some of the Best Large-Cap Stocks to Buy?
- Grocery Costs and Tariffs Now Top of Mind in Everyday Conversations, New Survey Finds
- How to Profit From Growth Investing
- Spotify Stock Eyes Double-Digit Upside—Is Now the Time to Buy?
Receive News & Ratings for BriaCell Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BriaCell Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
